ODEFSEY
Identification of Odefsey
| No description |
Google image searchProduct monograph
Active ingredients
emtricitabine, 200 MG
rilpivirine (rilpivirine hydrochloride), 25 MG
tenofovir alafenamide (tenofovir alafenamide hemifumarate), 25 MG
DIN: 02461463
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
Date: 20-MAR-2017
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR19 — EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND RILPIVIRINE (ATC/DDD)
Reference brand drug: Odefsey
